FDA approves Gilead’s twice-yearly HIV prevention injection, offering a powerful and convenient new option

In this article GILD Follow your favorite stocksCREATE FREE ACCOUNT The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead’s twice-yearly antiviral injection for preventing HIV – a milestone that the company and some experts say could…

Read More